Bullish indicating open at $55-$60, IPO prices at $37
Investing.com - Jefferies raised its price target on National Vision Holdings (NASDAQ:EYE) to $33.00 from $22.00 on Monday, while maintaining a Buy rating on the stock. The company, currently trading at $22.64 with a market capitalization of $1.79 billion, has shown impressive momentum with a 120% return over the past year. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value assessment.
The firm cited the $15 billion-plus anti-VEGF market’s increasing focus on reducing treatment burden, noting that most blockbuster treatments feature improved durability.
Jefferies highlighted that EYPT’s Phase 3 TKI insert could offer more than twice the durability compared to approved treatments, with positive outlook from their survey supporting their $1.4 billion adjusted estimate versus the $1.2 billion consensus.
The firm noted that derisked wet age-related macular degeneration (wAMD) pivotal trials with topline results expected in mid/second half of 2026 could position EYPT as an early entrant, with diabetic macular edema (DME) planned for 2026.
Jefferies finds EYPT attractively valued at approximately $450 million enterprise value, supporting their Buy rating and $33 price target on National Vision stock.
In other recent news, National Vision Holdings Inc. announced its financial results for the second quarter of 2025, which exceeded market expectations. The company reported earnings per share of $0.18, surpassing the projected $0.13, resulting in a 38.46% surprise. Revenue also exceeded forecasts, reaching $486.4 million compared to the anticipated $469.2 million. These results highlight a strong performance for the quarter. While there were no updates on mergers or acquisitions, the financial outcomes were significant. Analyst opinions or changes in stock ratings were not mentioned in the recent developments. The company did not report any other major news at this time. These recent developments provide investors with key insights into National Vision’s current financial standing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.